Details for 2019769220
Up to date per 04.04.2026
Actions
Details for 2019769220
Granted/Registered
European Patent
19.05.2021 A
31.08.2022 B1
10.07.2018
US
201862695993 P
05.11.2018
US
201862755588 P
C07D 309/10 20060101AFI20200117BHEP
Owner
GlaxoSmithKline Intellectual Property Development LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage, SG1 2NYGB
Fimbrion Therapeutics, Inc.20 South Sarah Street Saint Louis MO 63108US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
BISHOP, Michael JosephFive Moore Drive Research Triangle Park, NC 27709US
COLANDREA, Vincent J.1250 South Collegeville Road Collegeville, PA 19426US
LI, Yuehu1250 South Collegeville Road Collegeville, PA 19426US
STEWART, Eugene L.1250 South Collegeville Road Collegeville, PA 19426-0989US
STRAMBEANU, Iulia1250 South Collegeville Road Collegeville, PA 19426US
WIDDOWSON, Katherine Louisa3366 North Torrey Pines Court San Diego, CA 92106US
JANETKA, James Walter20 South Sarah Street Saint Louis, MO 63108US
MCGRANE, Laurel Kathryn20 South Sarah Street Saint Louis, MO 63108US
Information about Fees